Cargando…

A Prehepatectomy Circulating Exosomal microRNA Signature Predicts the Prognosis and Adjuvant Chemotherapeutic Benefits in Colorectal Liver Metastasis

SIMPLE SUMMARY: Exosomal miRNAs are associated with colorectal cancer liver metastasis (CRLM)-related biological behavior and prognosis. However, an exosomal miRNA signature predicting postoperative survival and the value of adjuvant chemotherapy for CRLM remains elusive. Using miRNA sequencing and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yun, Chen, Xiuxing, Lin, Haocheng, Sun, Xiaoqiang, Fong, William Pat, Wu, Xiaojun, Pan, Zhizhong, Yuan, Yunfei, Liang, Jieying, Wang, Deshen, Du, Ziming, Xing, Baocai, Li, Yuhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428239/ https://www.ncbi.nlm.nih.gov/pubmed/34503068 http://dx.doi.org/10.3390/cancers13174258

Ejemplares similares

Delineating the molecular landscape of different histopathological growth patterns in colorectal cancer liver metastases
por: Hu, Mingtao, et al.
Publicado: (2022)

Tumor‐infiltrating neutrophils predict prognosis and adjuvant chemotherapeutic benefit in patients with biliary cancer
por: Wang, Jie, et al.
Publicado: (2018)

Pathological complete response to immune checkpoint inhibitor in patients with colorectal cancer liver metastases harboring POLE exonuclease domain mutation
por: Wen, Lei, et al.
Publicado: (2022)

Immunoscore Signature Predicts Postoperative Survival and Adjuvant Chemotherapeutic Benefits in Esophageal Squamous Cell Carcinoma
por: Zhuge, Lingdun, et al.
Publicado: (2020)

Tumor-infiltrating mast cells predict prognosis and gemcitabine-based adjuvant chemotherapeutic benefit in biliary tract cancer patients
por: Bo, Xiaobo, et al.
Publicado: (2018)

Intratumoral PD-1(+)CD8(+) T cells associate poor clinical outcomes and adjuvant chemotherapeutic benefit in gastric cancer
por: Yu, Kuan, et al.
Publicado: (2022)

Is there a survival benefit from adjuvant chemotherapy for patients with liver oligometastases from colorectal cancer after curative resection?
por: Pan, Zhizhong, et al.
Publicado: (2018)

Exosomes as a Nano-Carrier for Chemotherapeutics: A New Era of Oncology
por: Araldi, Rodrigo Pinheiro, et al.
Publicado: (2023)

Neoadjuvant and Adjuvant Chemotherapeutic Strategy of Colorectal Mixed Adeno-Neuroendocrine Carcinomas
por: Michael, Anita, et al.
Publicado: (2021)

Benefits of annual chemotherapeutic control of schistosomiasis on the development of protective immunity
por: Chisango, Tawanda J., et al.
Publicado: (2019)

Chemotherapeutic treatment efficacy and sensitivity are increased by adjuvant alternating electric fields (TTFields)
por: Kirson, Eilon D, et al.
Publicado: (2009)

Adjuvant effects of chemotherapeutics and Metformin on MFE-319 endometrial carcinoma cell line
por: Aydemir, Isil, et al.
Publicado: (2020)

Elderly patients with stage II gastric cancer do not benefit from adjuvant chemotherapy
por: Guo, Jianping, et al.
Publicado: (2023)

Radiomics signature of computed tomography imaging for prediction of survival and chemotherapeutic benefits in gastric cancer
por: Jiang, Yuming, et al.
Publicado: (2018)

Embryonic Stem Cells‐Derived Exosomes Endowed with Targeting Properties as Chemotherapeutics Delivery Vehicles for Glioblastoma Therapy
por: Zhu, Qingwei, et al.
Publicado: (2019)

Exosome–Autophagy Crosstalk in Enveloped Virus Infection
por: Wang, Yuqi, et al.
Publicado: (2023)

Targeting Notch to Maximize Chemotherapeutic Benefits: Rationale, Advanced Strategies, and Future Perspectives
por: Zhdanovskaya, Nadezda, et al.
Publicado: (2021)

Blood TfR+ exosomes separated by a pH-responsive method deliver chemotherapeutics for tumor therapy
por: Yang, Lijun, et al.
Publicado: (2019)

l-Lysine-Based Gelators for the Formation of Oleogels in Four Vegetable Oils
por: Li, Qiannan, et al.
Publicado: (2022)

Hepatectomy plus adjuvant transcatheter arterial chemoembolization improves the survival rate of patients with multicentric occurrence of hepatocellular carcinoma
por: Xu, Da, et al.
Publicado: (2018)

The Chemotherapeutic Agent DMXAA as a Unique IRF3-Dependent Type-2 Vaccine Adjuvant
por: Tang, Choon Kit, et al.
Publicado: (2013)

Exosome removal as a therapeutic adjuvant in cancer
por: Marleau, Annette M, et al.
Publicado: (2012)

Survival benefit of patients with early-stage ovarian carcinoma treated with paclitaxel chemotherapeutic regimens
por: Chen, Chien-An, et al.
Publicado: (2018)

Blood TfR+ exosomes separated by a pH-responsive method deliver chemotherapeutics for tumor therapy: Erratum
por: Yang, Lijun, et al.
Publicado: (2021)

Protective Effects of Genistein against Mono-(2-ethylhexyl) Phthalate-Induced Oxidative Damage in Prepubertal Sertoli Cells
por: Zhang, Liandong, et al.
Publicado: (2017)

Exosome-Encased Nucleic Acid Scaffold Chemotherapeutic Agents for Superior Anti-Tumor and Anti-Angiogenesis Activity
por: McNamara, Ryan P., et al.
Publicado: (2022)

Inhibitory effect of valproic acid on bladder cancer in combination with chemotherapeutic agents in vitro and in vivo
por: WANG, DEGUI, et al.
Publicado: (2013)

Radiomic signature of( 18)F fluorodeoxyglucose PET/CT for prediction of gastric cancer survival and chemotherapeutic benefits
por: Jiang, Yuming, et al.
Publicado: (2018)

The Role of Exosome and the ESCRT Pathway on Enveloped Virus Infection
por: Ju, Yichen, et al.
Publicado: (2021)

Tumor-infiltrating IL-17A(+) cells determine favorable prognosis and adjuvant chemotherapeutic response in muscle-invasive bladder cancer
por: Wang, Zewei, et al.
Publicado: (2020)

An immune-related lncRNA signature predicts prognosis and adjuvant chemotherapeutic response in patients with small-cell lung cancer
por: Zhang, Zhihui, et al.
Publicado: (2021)

l-Lysine-Based Gelators for the Formation of Gels in Water and Alcohol–Water Mixtures
por: Miao, Yue, et al.
Publicado: (2022)

CHEMOTHERAPEUTIC EQUILIBRIA
por: Stearn, Allen E., et al.
Publicado: (1930)

Chemotherapeutic Antiseptics
por: Browning, C. H.
Publicado: (1937)

Comparative study of adjuvant chemotherapeutic efficacy of docetaxel plus cyclophosphamide and doxorubicin plus cyclophosphamide in female breast cancer
por: Adeel, Muhammad, et al.
Publicado: (2019)

Karyotyping of circulating tumor cells for predicting chemotherapeutic sensitivity and efficacy in patients with esophageal cancer
por: Chen, Yingjie, et al.
Publicado: (2019)

Diverse effects of chemotherapeutic agents on immune cell function and implications in immunochemotherapy
por: Glorieux, Christophe, et al.
Publicado: (2021)

Magnetic Drug Targeting Reduces the Chemotherapeutic Burden on Circulating Leukocytes
por: Janko, Christina, et al.
Publicado: (2013)

GSDME Increases Chemotherapeutic Drug Sensitivity by Inducing Pyroptosis in Retinoblastoma Cells
por: Li, Fang, et al.
Publicado: (2022)

Intratumoral interleukin-9 delineates a distinct immunogenic class of gastric cancer patients with better prognosis and adjuvant chemotherapeutic response
por: Fang, H., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4tsnjmidtjs7cf16dksvp79uhl